| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 196.55M | 111.92M | 66.40M | 44.71M | 22.59M | 1.22M |
| Gross Profit | 172.01M | 100.55M | 59.91M | 38.83M | 8.39M | 710.01K |
| EBITDA | 76.02M | 6.76M | 23.78M | 34.81M | 1.03M | 662.02K |
| Net Income | 11.04M | -23.96M | 9.52M | 31.68M | 997.41K | 662.02K |
Balance Sheet | ||||||
| Total Assets | 918.94M | 874.16M | 331.83M | 59.09M | 1.84M | 1.46M |
| Cash, Cash Equivalents and Short-Term Investments | 86.42M | 131.94M | 27.84M | 30.05M | 102.42K | 135.27K |
| Total Debt | 414.48M | 385.91M | 141.74M | 28.33M | 1.05M | 148.97K |
| Total Liabilities | 479.34M | 450.87M | 167.76M | 30.95M | 1.07M | 160.70K |
| Stockholders Equity | 439.59M | 424.15M | 163.93M | 27.25M | 915.05K | 2.08M |
Cash Flow | ||||||
| Free Cash Flow | -111.14M | -209.62M | -64.71M | 10.61M | 1.12M | 650.13K |
| Operating Cash Flow | -110.22M | -208.81M | -64.52M | 10.69M | 1.34M | 650.13K |
| Investing Cash Flow | -17.77M | -4.96M | 2.24M | -3.70M | -241.53K | -1.25M |
| Financing Cash Flow | 195.00M | 320.12M | 57.82M | 22.96M | -354.58K | 697.81K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $3.66B | 4.34 | 16.27% | ― | 27.71% | ― | |
71 Outperform | $4.10B | 18.74 | 11.12% | 1.54% | -1.61% | 15.79% | |
68 Neutral | $59.56M | 12.95 | 4.75% | 0.74% | 11.99% | ― | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
63 Neutral | $868.05M | 113.70 | 3.17% | ― | 91.78% | ― | |
63 Neutral | $3.54B | 16.62 | 2.86% | ― | 1.41% | 150.35% | |
59 Neutral | $298.26M | 27.06 | 5.02% | ― | -0.55% | -51.14% |
On January 30, 2026, Abacus Global Management announced that its board of directors had approved a $20 million share repurchase program, effective immediately and running through May 6, 2027, as part of its capital allocation strategy. The buyback, to be funded with cash on hand and free cash flow and executed via open-market and privately negotiated transactions, signals the board’s confidence in Abacus’s long-term business model, recurring earnings, and capital strength, while aiming to balance continued investment in growth, technology, and acquisitions with returning capital to shareholders.
The most recent analyst rating on (ABX) stock is a Buy with a $10.00 price target. To see the full list of analyst forecasts on Abacus Global Management stock, see the ABX Stock Forecast page.
In a shareholder letter released on January 8, 2026, Abacus Global Management reported that 2025 was a defining year, highlighted by record third-quarter results with year-over-year revenue growth of 124%, adjusted net income growth of 60%, adjusted EBITDA growth of 127% with 60% margins, and 10 consecutive quarters of beating earnings expectations. The company raised its full-year 2025 adjusted net income guidance to $80–$84 million, reflecting 72%–81% growth and a higher earnings and cash-flow baseline, while advancing a strategic shift from largely transactional income toward a recurring revenue model—currently about 15% of revenue, with a long-term target of 70%—supported by assets under management rising to $3.33 billion and strengthened by the acquisition of digital life insurance platform AccuQuote and the introduction of a dividend and share repurchase program. Abacus underscored key milestones including the completion of a $50 million investment-grade securitized note backed by life insurance assets, which broadens institutional distribution and establishes a repeatable, lower-cost funding mechanism while generating ongoing servicing fees, and the planned 2026 launch of an asset-based finance investing strategy aimed at deploying third-party capital into asset-backed lending and structured credit, leveraging the firm’s actuarial expertise and insurance infrastructure in a market it estimates at more than $20 trillion. Management emphasized a robust balance sheet, record cash generation, and confidence that growth can be funded without additional equity issuance—implying no expected shareholder dilution—while also addressing the company’s valuation discount relative to faster-growing alternative asset management peers and outlining intensified investor outreach efforts designed to increase transparency, highlight fee-related earnings, and close the gap in market perception.
The most recent analyst rating on (ABX) stock is a Hold with a $9.00 price target. To see the full list of analyst forecasts on Abacus Global Management stock, see the ABX Stock Forecast page.